Andromeda Metals Statistics

Total Valuation

ASX:ADN has a market cap or net worth of AUD 69.35 million. The enterprise value is 62.58 million.

Market Cap	69.35M
Enterprise Value	62.58M

Important Dates

The next estimated earnings date is Thursday, March 12, 2026.

Earnings Date	Mar 12, 2026
Ex-Dividend Date	n/a

Share Statistics

ASX:ADN has 4.62 billion shares outstanding. The number of shares has increased by 9.89% in one year.

Current Share Class	4.62B
Shares Outstanding	4.62B
Shares Change (YoY)	+9.89%
Shares Change (QoQ)	+4.67%
Owned by Insiders (%)	7.71%
Owned by Institutions (%)	1.43%
Float	4.12B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	0.44
P/TBV Ratio	0.44
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-10.36
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-6.92

Financial Position

The company has a current ratio of 4.56, with a Debt / Equity ratio of 0.00.

Current Ratio	4.56
Quick Ratio	4.48
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	-0.04
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -3.86% and return on invested capital (ROIC) is -2.37%.

Return on Equity (ROE)	-3.86%
Return on Assets (ROA)	-2.33%
Return on Invested Capital (ROIC)	-2.37%
Return on Capital Employed (ROCE)	-3.75%
Weighted Average Cost of Capital (WACC)	15.74%
Revenue Per Employee	n/a
Profits Per Employee	-2.01M
Employee Count	3
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +150.00% in the last 52 weeks. The beta is 2.10, so ASX:ADN's price volatility has been higher than the market average.

Beta (5Y)	2.10
52-Week Price Change	+150.00%
50-Day Moving Average	0.01
200-Day Moving Average	0.01
Relative Strength Index (RSI)	52.61
Average Volume (20 Days)	7,578,017

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-5.94M
Pretax Income	-6.04M
Net Income	-6.04M
EBITDA	-5.62M
EBIT	-5.94M
Earnings Per Share (EPS)	-0.00

Full Income Statement

Balance Sheet

The company has 7.14 million in cash and 365,436 in debt, with a net cash position of 6.78 million or 0.00 per share.

Cash & Cash Equivalents	7.14M
Total Debt	365,436
Net Cash	6.78M
Net Cash Per Share	0.00
Equity (Book Value)	157.93M
Book Value Per Share	0.04
Working Capital	6.86M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -4.77 million and capital expenditures -4.28 million, giving a free cash flow of -9.05 million.

Operating Cash Flow	-4.77M
Capital Expenditures	-4.28M
Free Cash Flow	-9.05M
FCF Per Share	-0.00

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ASX:ADN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-9.89%
Shareholder Yield	-9.89%
Earnings Yield	-8.71%
FCF Yield	-13.05%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on April 19, 2017. It was a forward split with a ratio of 1.145842882.

Last Split Date	Apr 19, 2017
Split Type	Forward
Split Ratio	1.145842882

Scores

Altman Z-Score	n/a
Piotroski F-Score	2